Recent Posts

• 
  Epignostix announces CMS release of a preliminary gapfill price for their proprietary CPT Code for the Epignostix CNS Tumor Methylation Classifier test2025-05-06
• 
  Epignostix launches CNS and sarcoma diagnostic tumor classifier applications2025-01-22
• 
  Heidelberg Epignostix appoints Helge Lubenow as CEO 2024-07-16
• DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier2024-07-02
• 
  Heidelberg Epignostix is live!2023-11-13

Categories

• Press Releases 5

Tag Cloud